Donor Login
Contact Us
JDRF
About
Investment Strategy
Portfolio
Our People
Venture Philanthropy
News
Donor Login
Get in touch
News and Press
Interview with portfolio company Enthera Pharmaceuticals on patented selective inhibitor molecules
July 26, 2021
IM Therapeutics Reports Positive Results in Safety, Tolerability and Mechanism of Action of Phase 1b Trial of Lead Drug IMT-002 in Type 1 Diabetes
July 21, 2021 |
WOBURN, MASS
Lilly Announces Acquisition of Protomer Technologies
July 14, 2021 |
INDIANAPOLIS, IN
Kriya Therapeutics Completes $100 Million Series B Financing to Advance Its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies
July 14, 2021 |
REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C.
T1D Fund in the News
Quest to Help Diabetic Son Endures With a Different Kind of Giving
July 02, 2021 |
New York Times
